// startup autopsy

Pantec Biosolutions

Drug delivery innovation lost in the valley of death.

marketfitSlow Death

Years-long decline before final shutdown · Fatal mistake: Pursued capital-intensive biotech development from a small jurisdiction without securing anchor pharma partnerships or sufficient runway to reach regulatory milestones.

Founded	2003
Closed	2012
Country	LIE
Sector	Biotech

50%

Key Events Timeline

2003-01-01

FOUNDING

Pantec Biosolutions founded in Liechtenstein to develop transdermal drug delivery technologies.

2007-01-01

FUNDING

Secured approximately $5.6M in funding to advance transdermal platform development.

2009-01-01

PRODUCT LAUNCH

Advanced transdermal technology toward preclinical or early clinical testing phases.

2011-01-01

PIVOT

Attempted to license technology to pharmaceutical partners to extend runway as internal capital depleted.

2012-06-01

SHUTDOWN

Pantec Biosolutions ceased operations after failing to secure further investment or commercial partnerships.

Full Analysis

Analyst plan

Documented cause

Pantec Biosolutions, a Liechtenstein-based biotech company, developed transdermal drug delivery technology but ultimately failed to achieve commercial viability. The company's primary challenges stemmed from re...

gulatory hurdles and inability to secure strategic partnerships with major pharmaceutical companies. Despite initial promise in developing transdermal delivery systems, Pantec could not navigate the c

Verified lesson

“...”

Unlock full lesson →

€20M

Peak valuation

HypeCycle · MoatType · ResearchTags

Pantec Biosolutions raised €5.5917159763313595M before pursued capital-intensive biotech development from a small jurisdiction without securing anchor pharma partnerships or sufficient runway to reach regulatory milestones. ended it. See the documented cause, verified lesson and all failure signals.

Unlock full analysis →Create free account

See all plans·Analyst plan — €149/mo